These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31987131)

  • 1. An immuno-MALDI mass spectrometry assay for the oral cancer biomarker, matrix metalloproteinase-1, in dried saliva spot samples.
    Hsiao YC; Lin SY; Chien KY; Chen SF; Wu CC; Chang YT; Chi LM; Chu LJ; Chiang WF; Chien CY; Chang KP; Chang YS; Yu JS
    Anal Chim Acta; 2020 Mar; 1100():118-130. PubMed ID: 31987131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary proteomics of canine oral tumors using MALDI-TOF mass spectrometry and LC-tandem mass spectrometry.
    Ploypetch S; Roytrakul S; Jaresitthikunchai J; Phaonakrop N; Krobthong S; Suriyaphol G
    PLoS One; 2019; 14(7):e0219390. PubMed ID: 31318878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma.
    Stott-Miller M; Houck JR; Lohavanichbutr P; Méndez E; Upton MP; Futran ND; Schwartz SM; Chen C
    Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2628-36. PubMed ID: 21960692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.
    Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW
    Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of SCARA5 as a Potential Biomarker for Oral Squamous Cell Carcinoma using MALDI-TOF-MS Analysis.
    Liu Y; Tan YR; Sun WW; Ju WT; Fu Y; Wang LZ; Li J; Zhang CP; Zhang ZY; Zhong LP
    Proteomics Clin Appl; 2018 Sep; 12(5):e1700180. PubMed ID: 29461673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic model of saliva peptide finger print analysis of oral squamous cell carcinoma patients using weak cation exchange magnetic beads.
    Jiang WP; Wang Z; Xu LX; Peng X; Chen F
    Biosci Rep; 2015 May; 35(3):. PubMed ID: 26182373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Multiplexed Assay for Oral Cancer Candidate Biomarkers Using Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry.
    Hsiao YC; Chi LM; Chien KY; Chiang WF; Chen SF; Chuang YN; Lin SY; Wu CC; Chang YT; Chu LJ; Chen YT; Chia SL; Chien CY; Chang KP; Chang YS; Yu JS
    Mol Cell Proteomics; 2017 Oct; 16(10):1829-1849. PubMed ID: 28821604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of glutathione S-transferase pi correlates with poorly differentiated grade in patients with oral squamous cell carcinoma.
    Ma HL; Yu C; Liu Y; Tan YR; Qiao JK; Yang X; Wang LZ; Li J; Chen Q; Chen FX; Zhang ZY; Zhong LP
    J Oral Pathol Med; 2015 Mar; 44(3):193-200. PubMed ID: 25047743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening of saliva for early detection of oral cancer: a pilot study.
    Szanto I; Mark L; Bona A; Maasz G; Sandor B; Gelencser G; Turi Z; Gallyas F
    Technol Cancer Res Treat; 2012 Apr; 11(2):181-8. PubMed ID: 22335413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages.
    Jou YJ; Lin CD; Lai CH; Tang CH; Huang SH; Tsai MH; Chen SY; Kao JY; Lin CW
    Clin Chim Acta; 2011 Jul; 412(15-16):1357-65. PubMed ID: 21497587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma.
    Lee LT; Wong YK; Hsiao HY; Wang YW; Chan MY; Chang KW
    Int J Oral Maxillofac Surg; 2018 Jun; 47(6):699-707. PubMed ID: 29174861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan.
    Yu JS; Chen YT; Chiang WF; Hsiao YC; Chu LJ; See LC; Wu CS; Tu HT; Chen HW; Chen CC; Liao WC; Chang YT; Wu CC; Lin CY; Liu SY; Chiou ST; Chia SL; Chang KP; Chien CY; Chang SW; Chang CJ; Young JD; Pao CC; Chang YS; Hartwell LH
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11549-11554. PubMed ID: 27663741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma.
    Malhotra R; Urs AB; Chakravarti A; Kumar S; Gupta VK; Mahajan B
    Tumour Biol; 2016 Jul; 37(7):9263-71. PubMed ID: 26779624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary proteomic analysis of diabetic patients for possible oral squamous cell carcinoma biomarkers.
    Jancsik VA; Gelencser G; Maasz G; Schmidt J; Molnar GA; Wittmann I; Olasz L; Mark L
    Pathol Oncol Res; 2014 Jul; 20(3):591-5. PubMed ID: 24343817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical validation of a saliva-based matrix metalloproteinase-1 rapid strip test for detection of oral cavity cancer.
    Chu LJ; Chang YT; Chien CY; Chung HC; Wu SF; Chen CJ; Liu YC; Liao WC; Chen CH; Chiang WF; Chang KP; Wang JS; Yu JS
    Biomed J; 2024 Feb; 47(1):100594. PubMed ID: 37044249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of salivary metabolite biomarkers for early monitoring of oral cancer with ultra performance liquid chromatography-mass spectrometry.
    Wang Q; Gao P; Cheng F; Wang X; Duan Y
    Talanta; 2014 Feb; 119():299-305. PubMed ID: 24401418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
    Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
    Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
    Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
    Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
    Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer.
    Chang YT; Chu LJ; Liu YC; Chen CJ; Wu SF; Chen CH; Chang IY; Wang JS; Wu TY; Dash S; Chiang WF; Chiu SF; Gou SB; Chien CY; Chang KP; Yu JS
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.